Monitoring of minimal residual disease after allografting: a requirement to guide DLI treatment?
Dazzi
F
F
Dept of Haematology, Imperial College Faculty of Medicine, Hammersmith Campus, London, UK.
D001782:Blood Donors; D006086:Graft vs Host Disease; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D017710:Lymphocyte Transfusion; D018365:Neoplasm, Residual / Q000175:diagnosis*; D012074:Remission Induction; D033581:Stem Cell Transplantation; D014184:Transplantation, Homologous